Deferasirox Tablet
Product Images NDC 70700-271

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 70700-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferasirox Tablets (Figure1)

A bar graph illustrating changes in liver iron content (mg Fe/g dry weight) and serum ferritin levels (mcg/L) at different Deferasirox doses (5, 10, 20, and 30 mg/kg/day). Liver iron content changes are shown with white bars; serum ferritin changes with black bars, with sample sizes noted below each dose group.*

FDA Label Image

Deferasirox Tablets 90 mg (30's Pack Label)

Deferasirox Tablets 90 mg film-coated oral tablets label. The package contains 30 tablets and is manufactured for Xiromed, LLC. Storage instructions specify 25°C (77°F) with permitted excursions from 15° to 30°C. The label includes a barcode, drug identification, and warnings to keep the medication away from children.*

FDA Label Image

Deferasirox Lab2

Label for Deferasirox Tablets 180 mg oral tablets, containing 30 tablets per package. The label includes storage instructions, manufacturer Xiromed, LLC, and advises dispensing the accompanying medication guide. The product is made in India and the label features a barcode and NDC 70700-270-30.*

FDA Label Image

Deferasirox Tablets 360 mg (30's Pack Label)

Label for Deferasirox Tablets 360 mg oral tablets manufactured by Xiromed, LLC. The label indicates a 30-tablet count and includes storage instructions and warnings. The label features the NDC 70700-271-30 and indicates the product is prescription only.*

FDA Label Image

Logo (Deferasirox Logo)

FDA Label Image

Deferasirox (Structure)

Chemical structure diagram of the active ingredient Deferasirox, showing its molecular framework with hydroxyl, carboxyl, and aromatic ring groups clearly depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.